Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure
Top Cited Papers
- 1 April 2007
- Vol. 93 (4) , 476-482
- https://doi.org/10.1136/hrt.2006.089656
Abstract
Background: Two ways to evaluate the symptoms of heart failure are the New York Heart Association (NYHA) classification and asking patients how far they can walk (walk distance). The NYHA system is commonly used, although it is not clear how individual clinicians apply it. Aim: To investigate how useful these measures are to assess heart failure and whether other questions might be more helpful. Methods: 30 cardiologists were asked what questions they used when assessing patients with heart failure. To assess interoperator variability, two cardiologists assessed a series of 50 patients in classes II and III using the NYHA classification. 45 patients who had undergone cardiopulmonary testing were interviewed using a specially formulated questionnaire. They were also asked how far they could walk before being stopped by symptoms, and then tested on their ability to estimate distance. Results: The survey of cardiologists showed no consistent method for assessing NYHA class and a literature survey showed that 99% of research papers do not reference or describe their methods for assigning NYHA classes. The interoperator variability study showed only 54% concordance between the two cardiologists. 70% of cardiologists asked patients for their walk distance; however, this walk distance correlated poorly with actual exercise capacity measured by cardiopulmonary testing (ρ = 0.04, p = 0.82). Conclusion: No consistent method of assessing NYHA class is in use and the interoperator study on class II and class III patients gave a result little better than chance. Some potential questions are offered for use in assessment. Walking distance, although frequently asked, does not correlate with formally measured exercise capacity, even after correction for patient perception of distance, and has never been found to have prognostic relevance. Its value is therefore doubtful.Keywords
This publication has 24 references indexed in Scilit:
- High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefitAmerican Heart Journal, 2004
- Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: symptomatic cardiac obstruction–pilot study of enalapril in aortic stenosis (SCOPE-AS)American Heart Journal, 2004
- Midterm Benefits of Left Univentricular Pacing in Patients With Congestive Heart FailureCirculation, 2004
- Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure?European Journal of Heart Failure, 2004
- Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker Valsartan in Patients With Chronic Heart FailureCirculation, 2003
- Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II))Clinical Research in Cardiology, 2003
- Hemodynamic and Neurohumoral Effects of Selective Endothelin A (ET A ) Receptor Blockade in Chronic Heart FailureCirculation, 2002
- Predictors of prognosis in patients with stable mild to moderate heart failureJournal of Cardiac Failure, 2000
- Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratificationHeart, 2000
- Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.Circulation, 1981